ACADIA PHARMACEUTICALS INC (ACAD)

US0042251084 - Common Stock

16.38  -0.21 (-1.27%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
726.44M517.20M484.10M441.80M339.10M
Cost Of Goods
41.64M10.20M18.00M20.60M19.60M
Gross Profit
684.80M507.10M466.10M421.20M319.50M
Operating Expenses
758.18M730.60M636.60M707.70M566.00M
Research and Development
351.62M361.60M239.40M319.10M240.40M
Selling, General, and Administrative Expenses
406.56M369.10M396.00M388.70M325.60M
Operating Income
-73.38M-223.60M-170.40M-286.60M-246.50M
Interest Income/Expense
17.23M6.60M600.00K6.60M11.20M
Other Income/Expense
5.11M3.50M2.30M-1.00M1.00M
Income Before Taxes
-51.04M-213.40M-167.50M-281.00M-234.40M
Income Tax
10.25M2.50M400.00K600.00K900.00K
Net Income
-61.29M-216.00M-167.90M-281.60M-235.30M
EBITDA
-67.83M-221.57M-167.05M-283.66M-243.73M
 
Per Share Data
EPS Diluted Total Ops
-0.37-1.34-1.05-1.79-1.60
Non GAAP EPS
-0.38-0.97-1.05-1.80-1.60
 
Statistics
Gross Profit Margin
94.27%98.05%96.28%95.34%94.22%
Profit Margin
-8.44%-41.76%-34.68%-63.74%-69.39%
Operating Profit Margin
-10.10%-43.23%-35.20%-64.87%-72.69%

All data in USD

Charts